Matthew Buten

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Buten:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. Chief Financial Officer Common Shares 195,652 $1,942,824 $9.93 05 Jan 2026 Direct
Biohaven Ltd. Chief Financial Officer Stock Options (Right to buy) 104,000 05 Jan 2025 Direct
Biohaven Ltd. Chief Financial Officer Restricted Share Unit Award 8,500 05 Jan 2026 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Common Shares 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Matthew Buten

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BHVN Biohaven Ltd. 05 Jan 2026 3 -$25,758 4 Chief Financial Officer 07 Jan 2026, 21:33
BHVN Biohaven Ltd. 05 Jan 2025 5 -$98,957 4 Chief Financial Officer 07 Jan 2025, 20:49
BHVN Biohaven Ltd. 02 Jan 2024 1 $0 4 Chief Financial Officer 04 Jan 2024, 20:07
BHVN Biohaven Ltd. 02 Nov 2023 1 $0 4 Chief Financial Officer 06 Nov 2023, 20:34
BHVN Biohaven Ltd. 05 Oct 2023 1 +$499,994 4 Chief Financial Officer 06 Oct 2023, 07:38
BHVN Biohaven Ltd. 25 Oct 2022 1 +$1,499,998 4 Chief Financial Officer 26 Oct 2022, 18:21
BHVN Biohaven Ltd. 03 Oct 2022 10 -$5 4 Chief Financial Officer 05 Oct 2022, 17:36
/report/000156218022006959-buten-matthew-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 4 -$917,284 4 Chief Financial Officer 03 Oct 2022, 20:28
BHVN Biohaven Ltd. 22 Sep 2022 0 $0 3 Treasurer 28 Sep 2022, 20:51
/report/000156218022000358-buten-matthew-2022-01-07 Biohaven Pharmaceutical Holding Co Ltd. 07 Jan 2022 1 $0 4 Chief Financial Officer 07 Jan 2022, 20:19
/report/000156218022000183-buten-matthew-2021-12-31 Biohaven Pharmaceutical Holding Co Ltd. 31 Dec 2021 3 -$871,373 4 Chief Financial Officer 04 Jan 2022, 20:30
/report/000156218021007699-buten-matthew-2021-12-08 Biohaven Pharmaceutical Holding Co Ltd. 08 Dec 2021 1 $0 4 Officer 14 Dec 2021, 19:52
/report/000156218021007698-buten-matthew-2021-12-08 Biohaven Pharmaceutical Holding Co Ltd. 08 Dec 2021 0 $0 3 Officer 14 Dec 2021, 19:37